Constantine S. Tam and Sarah Kamel (2016) “Comment on Lipsky et al.: Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib”, Haematologica. Pavia, Italy, 101(3), pp. e123-e123. doi: 10.3324/haematol.2015.139030.